Director of News and Editorial Communications

Tom Breen

Tom Breen has been at UConn since 2012, serving as a news writer, deputy spokesperson, manager for special projects, UConn Today editor, and, as of January 2021, director of news and editorial communications. Prior to UConn, he worked as a reporter for The Associated Press, covering health care, religion, and state government in West Virginia and North Carolina, and before the AP, he worked at newspapers in Connecticut and Massachusetts. He is the author of two books about Christianity and contemporary culture, and has published short fiction in many periodicals and anthologies. A second-generation Husky, he earned a bachelor’s degree in political science in 2000. He is the co-founder of the award-winning UConn 360 podcast and has given presentations on UConn history to community groups throughout Connecticut. He lives in Manchester, is active in volunteer organizations, and recommends that you try the coconut flavor at the Dairy Bar.


Author Archive

The Berkshire Eagle

Berkshire County Students Get Some Free Jazz Lessons from UConn

Science 1

Magnetically Reconfigurable Ribbons Let Scientists ‘Program’ Liquids on Demand

Wang lab’s collaborative research of multistable soft structures steer flows and choreograph droplets in work published in Device

The Washington Post

Defuse Political Tension in Your Family with One Simple Question

Quantum Insider

CT Announces $121M Investment to Boost Economic Opportunities Created by Quantum

New Haven Independent

State Bets Big on Quantum

CT Insider

CT Officials Announce Up to $121M in Quantum Technology Investments

Government Technology

Connecticut May Invest Up to $121M in Quantum

Hartford Business Journal

UConn Launches Accelerated One-Year MBA Program

OHS Online

UConn’s Korey Stringer Institute Opens New Lab to Advance Occupational Heat-Safety Research

A pharmacist in a white coat examines the label on a prescription bottle with a patient.

FDA Recall of Blood Pressure Pills Due to Cancer-Causing Contaminant May Point to Higher Safety Risks in Older Generic Drugs

Prazosin, the drug being recalled, is prescribed to more than a half-million patients each year